Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Charles River Laboratories Intl (NY: CRL )

252.87 USD -12.61 (-4.75%)
Official Closing Price Updated: 6:24 PM EST, Jan 27, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 360,198
Open 260.26
Bid (Size) 252.10 (9)
Ask (Size) 328.45 (1)
Prev. Close 265.48
Today's Range 249.48 - 261.97
52wk Range 95.58 - 284.60
Shares Outstanding 47,911,809
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Charles River Laboratories Schedules Fourth-Quarter 2020 Earnings and 2021 Guidance Release and Conference Call
Charles River Laboratories schedules fourth-quarter 2020 earnings and 2021 guidance release and conference call. 
From Business Wire News Releases
Charles River Partners with JADE Biomedical to Expand Biologics Capabilities
Charles River announced that it has entered into a strategic partnership with JADE Biomedical to expand global biologics capabilities. 
From Business Wire News Releases

Performance

YTD
+1.28%
+1.28%
1 Month
+2.31%
+2.31%
3 Month
+10.30%
+10.30%
6 Month
+28.12%
+28.12%
1 Year
+63.60%
+63.60%

More News

Read More
Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
From Business Wire News Releases
Charles River Laboratories Acquires Distributed Bio
From Business Wire News Releases
Charles River Delivers Industry-First Deciphex Patholytix Digital Pathology Peer Review for GLP Studies
From Business Wire News Releases
IJK, FICO, GNRC, CRL: Large Outflows Detected at ETF
Tags ETFs
From ETF Channel
Contract Research Organization (CRO) Services Market Size, Share, Price, Trends, Growth, Analysis, Key Players, Outlook, Report, Forecast 2020-2025 | ExpertMarketResearch.com
Tags Reportedtimes Financial Content English
From iCrowdNewswire
Charles River and PathoQuest Strengthen Strategic Partnership
From Business Wire News Releases
After 523% Run Since IPO, Large Cap Leader CTLT Stock Tests New Breakout
From Investor's Business Daily
Strange: Bullish CRL Analysts Actually See -5.41% Downside
Tags ETFs
From ETF Channel
Charles River Laboratories to Present at Upcoming Investor Conferences
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.